EAM Investors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GF
FLAM
EAM Investors's NEO Position: Q3 2023 in Review
EAM Investors sold out of NeoGenomics (NEO) in Q3 2023, closing a stake of 45,855 shares — an estimated $737K sold.
EAM Investors first reported a position in NEO in Q2 2013 and held it in 19 quarters. The position peaked at $6.66M in Q4 2015. 283 funds tracked by Wall St. Rank hold NEO as of Q3 2023.
- EAM Investors reported no remaining NeoGenomics position as of Q3 2023 after selling out during the quarter.
- EAM Investors sold 45,855 NeoGenomics shares in Q3 2023, an estimated $737K.
- EAM Investors first reported a position in NeoGenomics in Q2 2013 and held it in 19 quarters.
- EAM Investors's NeoGenomics position peaked at $6.66M in Q4 2015.
- 283 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2023.
Based on EAM Investors's 13F filing for Q3 2023, filed 13 Nov 2023.